Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.


Effective August 24, 2021, FibroGen, Inc. terminated the Transition, Separation, and Consulting Agreement with K. Peony Yu, M.D. dated November 27, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses